MBRX

Moleculin Biotech Inc. Common Stock (MBRX)

Stock · NASDAQ · Health Care

$0.65as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$2.35
Industry
Biotechnology: Pharmaceutical Preparations

Moleculin Biotech Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • MBRX
    Moleculin Biotech Inc. Common Stock
    $0.65
    ▼ 5.66%
    Market cap $2.27MP/E
  • OGEN
    Oragenics Inc. Common Stock
    $0.5296
    ▼ 0.08%
    Market cap $2.39MP/E
    $0.4801$1.45
  • SBFM
    Sunshine Biopharma Inc. Common Stock
    $1.16
    ▼ 8.66%
    Market cap $2.48MP/E
    $1.01$24.3
  • ARTL
    Artelo Biosciences Inc. Common Stock
    $0.6619
    ▲ 0.14%
    Market cap $2.59MP/E
    $0.52$28.14
  • MTNB
    Matinas Biopharma Holdings Inc. Common Stock
    $0.1966
    ▼ 1.70%
    Market cap $1.93MP/E
    $0.178$2.14
  • CDT
    CDT Equity Inc. Common Stock
    $1.69
    ▼ 10.37%
    Market cap $1.81MP/E
    $1.62$2,928
  • SXTC
    China SXT Pharmaceuticals Inc. Class A Ordinary Shares
    $3
    ▼ 13.29%
    Market cap $2.94MP/E
    $3.1$83,758

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
146.0K
Total value held
$303.0K
Institutional holders
18
Top holders this quarter
  • Unknown75.0K
  • Unknown32.3K
  • Unknown13.9K
  • Unknown13.7K
  • Unknown4.4K
  • Unknown3.4K
  • Unknown1.8K
  • Unknown491
  • Unknown434
  • Unknown281

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.